Recent

% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • ghosttraderg ghosttraderg Aug 2, 2012 5:40 PM Flag

    EpiCept to Report Second Quarter

    EpiCept to Report Second Quarter 2012 Operating and Financial Results on August 8, 2012

    TARRYTOWN, N.Y.--(BUSINESS WIRE)-- Regulatory News:

    EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that it will host a conference call to discuss second quarter 2012 operating and financial results on Wednesday, August 8, 2012 at 9:00 a.m. Eastern time. The call will follow the release of these financial results earlier in the day at 12:01 a.m. Eastern time.

    To participate in the live call and be able to participate in the question and answer session, please dial from the U.S. and Canada (877) 809-8594 or from international locations (706) 758-9407 (please reference access code 17527052) prior to the start of the conference. The conference call will also be broadcast live in listen-only mode on the Internet and may be accessed at www.epicept.com. The webcast will be archived for 90 days.

    A telephone replay of the call will be available for seven days by dialing from the U.S. and Canada (855) 859-2056 or from international locations (404) 537-3406 (please reference reservation number 17527052).

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I would guess the cash is the most interesting to look at.The BOD/management has done nothing to cut costs!

      Sorry kosar lille your EPCT position in Avanza kapitalförsökring will be a huge loss.

      What happened with "all-in"? You are all-over the stock market with your rear mirror trades!

      -14% well some pattern is constant!

 
IMNP
1.85-0.02(-1.07%)Mar 27 4:00 PMEDT